Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:02 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 365.01 USD | -1.55% |
|
-2.30% | +32.66% |
| 09-23 | US companies face rise in cyber attacks | RE |
| 09-22 | West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says | MT |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 25,688 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 29.77% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 25,185 | 24,714 | 24,346 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 31.13% | -1.87% | -1.49% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 42.6x | 37x | 33.1x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 8.13x | 7.17x | 6.38x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.6x | 2.5x | 2.8x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.61x | 7.16x | 6.66x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 7.46x | 6.89x | 6.31x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 26.8x | 23.7x | 20.9x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 33.3x | 29.1x | 25.4x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 58.5x | 43.5x | 33.6x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.71% | 2.3% | 2.98% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.118 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.25% | 0.27% | 0.31% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.1% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,860 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 939.3 | 1,041 | 1,162 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.1 | 848.8 | 957 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 621.5 | 710.2 | 798.6 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -973.5 | -1,342 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 365.01 | 365.01 | 365.01 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 17/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 42.57x | 7.46x | 26.81x | 0.25% | 25.69B | ||
| 27.39x | 3.81x | 14.72x | 2.66% | 167B | ||
| 18.26x | 3.37x | 12.05x | 3.26% | 111B | ||
| 21.23x | 4.18x | 14.6x | 1.32% | 105B | ||
| 25.57x | 2.51x | 10.15x | 2.82% | 74.82B | ||
| 16.96x | 0.2x | 12.44x | 0.77% | 59.11B | ||
| 29.74x | 7.35x | 19.01x | 1.35% | 51.8B | ||
| 34.32x | 3.34x | 11.44x | 2.2% | 48.5B | ||
| 35.06x | 8.71x | 24.52x | -.--% | 40.79B | ||
| 34.65x | 6.08x | 19.07x | -.--% | 32.54B | ||
| Average | 28.58x | 4.70x | 16.48x | 1.46% | 71.58B | |
| Weighted average by Cap. | 25.98x | 4.10x | 14.90x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
















